@LaughinPaulRyan
10年前
... STREETS ARE WATCHING ...
NEW YORK (TheStreet) -- Mannatech (MTEX) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B-. TheStreet Ratings Team has this to say about their recommendation:
"We rate MANNATECH INC (MTEX) a BUY. This is driven by multiple strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year, impressive record of earnings per share growth, compelling growth in net income and notable return on equity. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results."
Highlights from the analysis by TheStreet Ratings Team goes as follows:
The revenue growth came in higher than the industry average of 5.8%. Since the same quarter one year prior, revenues rose by 25.2%. Growth in the company's revenue appears to have helped boost the earnings per share.
Compared to where it was a year ago today, the stock is now trading at a higher level, reflecting both the market's overall trend during that period and the fact that the company's earnings growth has been robust. Looking ahead, unless broad bear market conditions prevail, we still see more upside potential for this stock, despite the fact that it has already risen over the past year.
MANNATECH INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. During the past fiscal year, MANNATECH INC turned its bottom line around by earning $1.18 versus -$0.53 in the prior year.
The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Personal Products industry. The net income increased by 737.7% when compared to the same quarter one year prior, rising from -$0.80 million to $5.11 million.
The company's current return on equity greatly increased when compared to its ROE from the same quarter one year prior. This is a signal of significant strength within the corporation. When compared to other companies in the Personal Products industry and the overall market, MANNATECH INC's return on equity exceeds that of the industry average and significantly exceeds that of the S&P 500.
stocktrademan
10年前
$MTEX DD Notes ~ http://www.ddnotesmaker.com/MTEX
bullish
good price action
inverted head and shoulders breakout
$MTEX recent news/filings
## source: finance.yahoo.com
Tue, 25 Nov 2014 23:58:12 GMT ~ Nasdaq stocks posting largest percentage increases
read full: http://sg.finance.yahoo.com/news/nasdaq-stocks-posting-largest-percentage-220237991--finance.html
*********************************************************
Tue, 18 Nov 2014 14:29:19 GMT ~ Mannatech Hosts Leadership Experience Event in Frisco, Texas
[at noodls] - Annual event celebrated launch of GlycoBOOM and the M5M Foundation COPPELL, Texas--(BUSINESS WIRE)--Nov. 18, 2014-- Mannatech®, Incorporated (NASDAQ: MTEX), the pioneer of nutritional glycobiology, leading ...
read full: http://www.noodls.com/view/F542286F94B737658E7FF116007F4509EBC13307
*********************************************************
Tue, 18 Nov 2014 14:00:00 GMT ~ Mannatech Hosts Leadership Experience Event in Frisco, Texas
[Business Wire] - Mannatech®, Incorporated , the pioneer of nutritional glycobiology, leading innovator of naturally-sourced supplements based on Real Food Technology® solutions and cr
read full: http://finance.yahoo.com/news/mannatech-hosts-leadership-experience-event-140000387.html
*********************************************************
Fri, 14 Nov 2014 18:04:34 GMT ~ MANNATECH INC Financials
read full: http://finance.yahoo.com/q/is?s=mtex
*********************************************************
Tue, 11 Nov 2014 16:14:57 GMT ~ Mannatech Announces Official Completion of the M5M? China Run
[at noodls] - Jason Lester completed 2,500-mile run in 83 days to raise awareness for malnutrition COPPELL, Texas--(BUSINESS WIRE)--Nov. 11, 2014-- Mannatech®, Incorporated (NASDAQ: MTEX), the pioneer of nutritional ...
read full: http://www.noodls.com/view/35C998E42C7F340FE3DA88342B12FDC39D8DB9CE
*********************************************************
$MTEX charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$MTEX company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/MTEX/company-info
Ticker: $MTEX
OTC Market Place: Not Available
CIK code: 0001056358
Company name: Mannatech, Inc.
Incorporated In: TX, USA
$MTEX share structure
## source: otcmarkets.com
Market Value: $63,744,349 a/o Nov 25, 2014
Shares Outstanding: 2,668,244 a/o Oct 31, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
$MTEX extra dd links
Company name: Mannatech, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/MTEX/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/MTEX/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=MTEX+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=MTEX+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=MTEX+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/MTEX/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/MTEX/news - http://finance.yahoo.com/q/h?s=MTEX+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/MTEX/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/MTEX/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/MTEX/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/MTEX/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/MTEX/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/MTEX/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/MTEX/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/MTEX/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=MTEX+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/MTEX
DTCC (dtcc.com): http://search2.dtcc.com/?q=Mannatech%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Mannatech%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Mannatech%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/MTEX/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/MTEX
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/MTEX/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/MTEX/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/MTEX/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001056358&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/MTEX/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/MTEX/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/MTEX/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/MTEX/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=MTEX&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=MTEX
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/MTEX/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=MTEX+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=MTEX+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=MTEX
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=MTEX
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=MTEX+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/MTEX/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=MTEX+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/MTEX.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=MTEX
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/MTEX/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/MTEX/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/MTEX/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/MTEX/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/MTEX
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/MTEX
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/MTEX:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=MTEX
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=MTEX
$MTEX DD Notes ~ http://www.ddnotesmaker.com/MTEX
investora2z
11年前
The fall may have stopped a little, but there is no sign of any strength in the stock. However, despite a huge correction from the highs, the stock is still 100% up from its 52 week low of $4.77 made in November last year. It is a very low volume stock and hence the volatility is very high. The stock may correct a little more and then stabilize. Thereafter, it may remain in a range till the next earnings. For the sentiments to change, the fundamentals have to improve substantially. It may take a few quarters of good performance to build some confidence in the future prospects of the company. Mainly the margins need to be improved so that a strong turnaround is achieved and sustained. Revenue growth is also important and for that it may look at innovative products being launched in the market. Chromadex Corporation (CDXC) has recently launched Nicotiniamide Riboside (NR) which is an innovative molecule being promoted as a wonder vitamin. The market for nutritional products is robust, and the company may benefit from the growth story. With proper focus and strategy, achieving revenue growth may not be that difficult. Improving margins may be the real test for the company. In any case, it may be sensible to avoid the earnings exposure for Mannatech next time around. There have been some management changes, but how they will translate into real numbers remains to be seen. But one good thing is that the expectations may have reduced significantly. Though the turnaround is slow, there has been improvement on a yoy basis for net income. However, the decline in revenues remains a matter of concern. In fact, it may be better if the company goes a little slow on revenue growth but manages to strengthen the bottom line.
investora2z
12年前
The stock has done well recently with a decent move after the declaration of the results. It has moved from $5.65 to around $6.5 which is a good 15% move. On a 52 week basis the stock is up by 63% and has nearly doubled from its 52 week low of $3.35. MTEX is now trading above its 50 DMA ($6.05) and 200 DMA ($5.98). The volumes for this stock are never high, and have come down after the earnings. The move is backed by the fact that the company showed a net profit in Q4'12 compared to net loss of $7 million. As per the management, the turnaround has been recent, and may be expected to continue in the current year. In case the company is able to report turnarounds in the next few quarters, the stock may start a uptrend. There have been other companies in the nutritional supplements market which have improved margins. e.g. MusclePharm (MSLP) improved gross and net margins significantly on a 267% growth in revenues to $78 million. Key to success for MTEX would be development of new products based on what the consumers want. It has been a great supporter of the “open innovation” concept where ideas come from the consumers telling the industry what it wants. The global launch of NutriVerus in May last year has helped the company increase its top line. More such products are required to continuously beat the competition. MTEX has very low debt on books, and is trading at a discount to its book value of $7.64 per share. The price to sales is very low at 0.10 which indicates that if the margins improve, there is tremendous scope for capital appreciation. The dividend yields at current prices will be high and that could be one more reason for adding the stock to its portfolio for the long term.
investora2z
12年前
The recently declared Q4'12 results of MTEX showed a decrease in sales of around 11.7% compared with Q4'11 ($42.3 million vs $47.9 million). Importantly, sales for US and Canada declined more (down by 14.4% from $23.6 million to $20.2 million) as compared with the decline in international sales (down by 9.1% from $24.3 million to $22.1 million). However, the company turned positive on the net income front, with a minor profit of $0.3 million in Q4'12 compared with a loss of $7 million in Q4'11. The CEO pointed out that the company had turned positive in the second half of the year. For the full year, the net sales in 2012 declined by 13.6% as compared with 2011 (from $200.7 million to $173.4 million). The net loss for the full year declined substantially. For 2012, the net loss was $1.4 million compared with a net loss of $20.7 million in 2011. The number of new independent associates and members for 2012 increased by 20,000 to 97,000. The CEO expressed his satisfaction about the success of its global launch NutriVerus in 2012. Meanwhile, the stock which has been on a long term downtrend, has shown some signs of stabilization since January 2012. Even more recently, last few trading sessions have seen much higher volumes, and the stock has gained a few percentage points indicating some sort of upward bias. The market for the nutritional supplements is growing, but the sales of the company are not. Comparing with newer players like MusclePharm (MSLP) which have shown good growth (from sales of $1 million in 2009 to $78 million in 2012), the company seems to be lacking behind. Even products like BluScience, sold by Chromadex (CDXC) to NutriSci recently, have been success stories. MTEX, therefore, has to continue its efforts to develop and acquire new products all the time. Success of NutriVerus is obviously encouraging.
apostrophe
17年前
I don't know.. vitamins?
I was surprised though to see that they seem to be turning a profit so far.
Isn't this one like kind of like Amway was where they have essentially some kind of pyramid marketting scheme: friends and family sell to other friends and family?
The name caught my eye because some people I know were swearing by, I believe, one of their products : glycemo - something...
On the other hand, if I were trying to be an amateur distributor for soap or whatever, I would probably want to have good things to say about it to whoever I met too...
Hard to say. I used to think NTRI would be a good short, waiting, waiting, but it keeps surprising me as well..